Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation

被引:67
作者
Silva, CL
Portaro, FCV
Bonato, VLD
de Camargo, ACM
Ferro, ES
机构
[1] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Microbiol Immunol & Parasitol, BR-14049900 Ribeirao Preto, Brazil
[2] Butantan Inst, Biochem & Biophys Lab, BR-05503900 Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Biomed Sci, Dept Histol & Embryol, BR-05508900 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
peptidase; antigen presentation; MHC class I;
D O I
10.1006/bbrc.1999.0250
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The initial processing of antigens leading to major histocompatibility complex (MHC) class I antigenic peptides is carried out by the proteasome, However, how the final epitopes are generated and protected from degradation by cytosolic peptidases remains unknown, Coincidentally, peptides associated with the MHC class I molecules range from 8 to 13 amino acid residues, similarly to the optimum substrate size required for the cytosolic thimet oligopeptidase, Here we have investigated the putative intracellular function of thimet oligopeptidase related to antigen presentation. Using a well-characterized antigen-presenting cell system, we were able to demonstrate either inhibition or stimulation of CD8 T cell proliferation and cytotoxicity, manipulating intracellular thimet oligopeptidase levels with its specific inhibitor cFP-Ala-Ala-Tyr-pAb or loading the enzyme itself into the antigen-presenting cells. Our results suggest that thimet oligopeptidase should take an important function in the pathway of antigen presentation via MHC class I through a mechanism yet unknown, (C) 1999 Academic Press.
引用
收藏
页码:591 / 595
页数:5
相关论文
共 27 条
  • [1] HUMAN TRANSPORTERS ASSOCIATED WITH ANTIGEN-PROCESSING POSSESS A PROMISCUOUS PEPTIDE-BINDING SITE
    ANDROLEWICZ, MJ
    CRESSWELL, P
    [J]. IMMUNITY, 1994, 1 (01) : 7 - 14
  • [2] BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529
  • [3] Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors
    Bogyo, M
    McMaster, JS
    Gaczynska, M
    Tortorella, D
    Goldberg, AL
    Ploegh, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) : 6629 - 6634
  • [4] Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice
    Bonato, VLD
    Lima, VMF
    Tascon, RE
    Lowrie, DB
    Silva, CL
    [J]. INFECTION AND IMMUNITY, 1998, 66 (01) : 169 - 175
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase
    Camargo, ACM
    Gomes, MD
    Reichl, AP
    Ferro, ES
    Jacchieri, S
    Hirata, IY
    Juliano, L
    [J]. BIOCHEMICAL JOURNAL, 1997, 324 : 517 - 522
  • [7] CAMARGO ACM, 1979, J BIOL CHEM, V254, P5304
  • [8] EVIDENCE THAT ENZYMATIC CONVERSION OF N-[1(R,S)-CARBOXY-3-PHENYLPROPYL]-ALA-ALA-PHE-P-AMINOBENZOATE, A SPECIFIC INHIBITOR OF ENDOPEPTIDASE 24.15, TO N-[1(R,S)-CARBOXY-3-PHENYLPROPYL]-ALA-ALA IS NECESSARY FOR INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME
    CARDOZO, C
    ORLOWSKI, M
    [J]. PEPTIDES, 1993, 14 (06) : 1259 - 1262
  • [9] PURIFICATION OF RABBIT BRAIN ENDOOLIGOPEPTIDASES AND PREPARATION OF ANTI-ENZYME ANTIBODIES
    CARVALHO, KM
    CAMARGO, ACM
    [J]. BIOCHEMISTRY, 1981, 20 (25) : 7082 - 7088
  • [10] CHECLER F, 1995, METHOD ENZYMOL, V248, P593